9 research outputs found
Additional file 1 of Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer
Additional file 1. Supplementary figures S1-S9
Supplementary Data 1 from Bcl-xL Is a Key Mediator of Apoptosis Following KRAS<sup>G12C</sup> Inhibition in <i>KRAS<sup>G12C</sup></i>-mutant Colorectal Cancer
antibodies</p
Supplementary Figures S1-S6 from Bcl-xL Is a Key Mediator of Apoptosis Following KRAS<sup>G12C</sup> Inhibition in <i>KRAS<sup>G12C</sup></i>-mutant Colorectal Cancer
Supplementary figures</p
Supplementary Data 2 from Bcl-xL Is a Key Mediator of Apoptosis Following KRAS<sup>G12C</sup> Inhibition in <i>KRAS<sup>G12C</sup></i>-mutant Colorectal Cancer
concentrations of drugs</p
Supplementary Materials and Methods SM1 from Bcl-xL Is a Key Mediator of Apoptosis Following KRAS<sup>G12C</sup> Inhibition in <i>KRAS<sup>G12C</sup></i>-mutant Colorectal Cancer
Supplementary materials and methods</p
Supplementary Table from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Supplementary Table from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cance
Supplementary Table from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Supplementary Table from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cance
Supplementary Figure from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Supplementary Figure from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cance
Supplementary Figure from Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients
Supplementary Figure from Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patient
